Neuroone Medical Technologies (NMTC) Income from Continuing Operations (2010 - 2026)
Neuroone Medical Technologies' (NMTC) quarterly Income from Continuing Operations came in at 2382022.0 in Q1 2026, down 4.91% YoY from 2504935.1 in Q1 2025, and down 65.66% on a QoQ basis from 1437890.0 in Q4 2025.
Neuroone Medical Technologies (NMTC) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Neuroone Medical Technologies (NMTC) has 17 years of Income from Continuing Operations data on file, last reported at 2382022.0 in Q1 2026.
- Quarterly Income from Continuing Operations fell 4.91% year-over-year to 2382022.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 6940001.0 (down 5.1% YoY) and the FY2025 annual result came in at 3605374.0, up 70.73% from the prior year.
- Income from Continuing Operations retreated to 2382022.0 in Q1 2026, from 1437890.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 1785322.0 in Q4 2024 to a low of 3522828.0 in Q1 2023.
- A 5-year average of 2282060.29 and a median of 2759727.0 in 2022 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2024 — Income from Continuing Operations surged 153.37% — and 2025, when it sank 180.54%.
- Tracing NMTC's Income from Continuing Operations over 5 years: stood at 1732769.0 in 2022, then slumped by 93.04% to 3344900.0 in 2023, then surged by 153.37% to 1785322.0 in 2024, then sank by 180.54% to 1437890.0 in 2025, then slumped by 65.66% to 2382022.0 in 2026.
- The last three Income from Continuing Operations figures came in at 2382022.0 (Q1 2026), 1437890.0 (Q4 2025), and 1619221.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Neuroone Medical Technologies | 19.40 Mn | 17.35 Mn | 1.18 Mn | -2.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.01 Mn |
| Mar 31, 2026 | -2.38 Mn |
| Dec 31, 2025 | -1.44 Mn |
| Sep 30, 2025 | -1.62 Mn |
| Jun 30, 2025 | -1.50 Mn |
| Mar 31, 2025 | -2.27 Mn |
| Dec 31, 2024 | 1.79 Mn |
| Sep 30, 2024 | -3.35 Mn |
| Jun 30, 2024 | -2.77 Mn |
| Mar 31, 2024 | -2.86 Mn |
| Dec 31, 2023 | -3.34 Mn |
| Sep 30, 2023 | -3.14 Mn |
| Jun 30, 2023 | -3.47 Mn |
| Mar 31, 2023 | -3.52 Mn |
| Dec 31, 2022 | -1.73 Mn |
| Sep 30, 2022 | -1.37 Mn |
| Jun 30, 2022 | -2.76 Mn |
| Mar 31, 2022 | -3.06 Mn |
| Dec 31, 2021 | -2.81 Mn |
| Sep 30, 2021 | -11.45 Mn |